BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2736 related articles for article (PubMed ID: 6322938)

  • 1. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro antitumor activities of tuftsin.
    Nishioka K; Babcock GF; Phillips JH; Banks RA; Amoscato AA
    Ann N Y Acad Sci; 1983; 419():234-41. PubMed ID: 6324636
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopharmacological properties of tuftsin and of some analogues.
    Florentin I; Martinez J; Maral J; Pelletier M; Chung V; Roch-Arveiller M; Bruley-Rosset M; Giroud JP; Winternitz F; Mathé G
    Ann N Y Acad Sci; 1983; 419():177-91. PubMed ID: 6424534
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumour effect of the physiological tetrapeptide, tuftsin.
    Nishioka K
    Br J Cancer; 1979 Mar; 39(3):342-5. PubMed ID: 582417
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of tuftsin.
    Nishioka K; Babcock GF; Phillips JH; Noyes RD
    Mol Cell Biochem; 1981 Dec; 41():13-8. PubMed ID: 6895773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuftsin-induced enhancement of murine and human natural cell-mediated cytotoxicity.
    Phillips JH; Nishioka K; Babcock GF
    Ann N Y Acad Sci; 1983; 419():192-204. PubMed ID: 6585168
    [No Abstract]   [Full Text] [Related]  

  • 9. The antineoplastic effects of tuftsin and tuftsinyltuftsin on B16/5B melanoma and L1210 cells.
    Najjar VA; Linehan L; Konopińska D
    Ann N Y Acad Sci; 1983; 419():261-7. PubMed ID: 6324637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antitumor activity of alpha-difluoromethyl ornithine by the immunomodulating peptide tuftsin.
    Sunkara PS; Prakash NJ; Nishioka K
    Ann N Y Acad Sci; 1983; 419():268-72. PubMed ID: 6424536
    [No Abstract]   [Full Text] [Related]  

  • 14. Ouabain promotes immune responses in WEHI-3 cells to generate leukemia mice through enhancing phagocytosis and natural killer cell activities in vivo.
    Shih YL; Shang HS; Chen YL; Hsueh SC; Chou HM; Lu HF; Lee MZ; Hou HT; Chuang YY; Lee MH; Chen KW; Chung JG
    Environ Toxicol; 2019 May; 34(5):659-665. PubMed ID: 30761740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS; Fischer PH; Prusoff WH
    Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
    Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
    Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phagocytic function of the macrophages in leukemic animals].
    Fan FF
    Eksp Med Morfol; 1976; 15(2):83-8. PubMed ID: 1278085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 137.